John Overdeck’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
1,046,279
-713,655
-41% -$1.41M ﹤0.01% 3064
2026
Q1
$3.34M Buy
1,759,934
+739,855
+73% +$1.27M ﹤0.01% 2349
2025
Q4
$1.62M Buy
1,020,079
+236,489
+30% +$496K ﹤0.01% 2592
2025
Q3
$1.83M Sell
783,590
-144,935
-16% -$274K ﹤0.01% 2192
2025
Q2
$1.17M Sell
928,525
-52,773
-5% -$51.9K ﹤0.01% 2154
2025
Q1
$896K Sell
981,298
-137,398
-12% -$179K ﹤0.01% 2238
2024
Q4
$1.78M Buy
1,118,696
+214,239
+24% +$431K ﹤0.01% 1799
2024
Q3
$1.77M Sell
904,457
-214,728
-19% -$440K ﹤0.01% 1753
2024
Q2
$1.84M Buy
1,119,185
+889,438
+387% +$2.84M ﹤0.01% 1612
2024
Q1
$1.18M Sell
229,747
-274,852
-54% -$1.69M ﹤0.01% 1848
2023
Q4
$2.89M Buy
504,599
+307,984
+157% +$1.52M 0.01% 1280
2023
Q3
$940K Buy
196,615
+146,989
+296% +$912K ﹤0.01% 1974
2023
Q2
$211K Buy
+49,626
New +$223K ﹤0.01% 2631
2023
Q1
Sell
-121,924
Closed -$766K 2998
2022
Q4
$766K Buy
+121,924
New +$1.08M ﹤0.01% 1839
2022
Q2
Sell
-24,456
Closed -$225K 2578
2022
Q1
$225K Buy
+24,456
New +$258K ﹤0.01% 2307

Other funds holding CRBU

John Overdeck's CRBU Position: Q2 2026 in Review

John Overdeck reduced its Caribou Biosciences (CRBU) stake by 41% in Q2 2026, selling an estimated $1.41M and leaving 1,046,279 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

John Overdeck first reported a position in CRBU in Q1 2022 and has held it in 15 quarters since. The position peaked at $3.34M in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • John Overdeck held 1,046,279 shares of Caribou Biosciences worth $1.84M as of Q2 2026.
  • John Overdeck sold 713,655 Caribou Biosciences shares in Q2 2026, an estimated $1.41M.
  • Caribou Biosciences made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3064 holding.
  • John Overdeck first reported a position in Caribou Biosciences in Q1 2022 and has held it in 15 quarters since.
  • John Overdeck's Caribou Biosciences position peaked at $3.34M in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.